Concepedia

Bayesian Monitoring Of Futility

Bayesian Monitoring of Futility is a statistical methodology within Bayesian clinical trial design that uses accumulating evidence to assess the probability that a treatment will fail to achieve a prespecified efficacy target, thereby guiding early termination decisions when continued experimentation is unlikely to demonstrate clinically meaningful benefit.

10

Publications

538

Citations

54

Authors

33

Institutions

Publications per year

2017–2026

4

Variants

Bayesian Futility Analysis

Parents

Publications

10

Bayesian predictive approach to interim monitoring in clinical trials

Alexei Dmitrienko, Ming‐Dauh Wang · Statistics in Medicine · 2005 · 131 citations

, , +16

TUTORIAL IN BIOSTATISTICS: BAYESIAN DATA MONITORING IN CLINICAL TRIALS

Peter Fayers, Deborah Ashby, Mahesh Parmar · Statistics in Medicine · 1997 · 119 citations

, , +11

[Investigating Therapies of Potentially Great Benefit: ECMO]: Comment: A Bayesian Perspective

Robert E. Kass, Joel B. Greenhouse · Statistical Science · 1989 · 74 citations · Full text

, , +5

Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial

Fergus Hamilton, Todd C. Lee, David Arnold et al. · International Journal of Infectious Diseases · 2021 · 49 citations · Full text

, , +14

Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer

Julie E. Bauman, Nabil F. Saba, Denise J. Roe et al. · Journal of Clinical Oncology · 2023 · 48 citations · Full text

, , +17

1–5 of 10

Authors

54

  1. MP
    Mahesh Parmar

    University College London, United Kingdom

    2 publications · 129 citations

    2

    h-index

  2. SW
    Steven Wang

    Janssen (Belgium), Belgium

    1 publications · 48 citations

    1

    h-index

  3. MJ
    Michael J. Silverberg

    Kaiser Permanente, United States

    1 publications · 13 citations

    1

    h-index

  4. JB
    Joel B. Greenhouse

    Carnegie Mellon University, United States

    1 publications · 74 citations

    1

    h-index

  5. RL
    Richard Lilford

    University of Birmingham, United Kingdom

    1 publications · 49 citations

    1

    h-index

1–5 of 54

Institutions

33

  1. Emory University

    Atlanta, United States

    2 h-index

    6 publications

    148 citations

  2. North Bristol NHS Trust

    Bristol, United Kingdom

    1 h-index

    2 publications

    98 citations

  3. Harvard University

    Cambridge, United States

    1 h-index

    1 publications

    16 citations

  4. Yale Cancer Center

    New Haven, United States

    1 h-index

    2 publications

    96 citations

  5. Wayne State University

    Detroit, United States

    1 h-index

    1 publications

    44 citations

  6. Arizona Oncology

    Tucson, United States

    1 h-index

    1 publications

    48 citations

  7. United States Food and Drug Administration

    Silver Spring, United States

    1 h-index

    4 publications

    136 citations

  8. Kaiser Permanente

    Oakland, United States

    1 h-index

    3 publications

    39 citations

1–8 of 33

Venues

  1. Statistics in Medicine

    3 publications · 260 citations

    3

    h-index

  2. Trials

    1 publications · 44 citations

    1

    h-index

  3. International Journal of Infectious Diseases

    IJID · 1 publications · 49 citations

    1

    h-index

  4. Statistical Science

    1 publications · 74 citations

    1

    h-index

  5. Journal of Clinical Oncology

    1 publications · 48 citations

    1

    h-index

1–5